KeyBanc upgrades Corteva to Overweight after Vylor spin‑off
KeyBanc Capital Markets raised its rating on Corteva Inc. (CTVA) to Overweight, saying the crop‑protection business is now a deep‑value opportunity following the separation of its seed unit, Vylor. Analyst Salvator Tiano set a $17 price target and highlighted expected earnings growth from new products, cost cuts and a strong balance sheet. The firm projects EBITDA to rise from about $1.32 billion in 2026 to $1.65 billion in 2029, with new product revenue adding roughly $800 million annually by 2029. Risks include a modest decline in the crop‑chemicals market and lingering PFAS liabilities.
Why it matters
KeyBanc expects the upgrade to support a higher share price as investors price in the projected earnings expansion and potential share repurchases. The firm also notes that Corteva could have more than $1.5 billion available for acquisitions or buybacks after ending 2026 with roughly $500 million of net cash.
Key facts
- 1KeyBanc raised Corteva's rating to Overweight from Sector Weight. tradingview.com
- 2Analyst Salvator Tiano set a $17 price target for Corteva. tradingview.com
- 3Corteva's shares trade at about 6.5 times KeyBanc's estimated 2027 EBITDA. tradingview.com
- 4KeyBanc forecasts EBITDA to increase from roughly $1.32 billion in 2026 to $1.65 billion in 2029. tradingview.com
- 5New crop‑protection products are expected to generate about $800 million of annual revenue by 2029 versus 2026. tradingview.com
- 6Corteva finished 2026 with approximately $500 million of net cash, implying over $1.5 billion could be used for acquisitions or share repurchases. tradingview.com
Summary written by AlphAI from 3 of 3 sources. Not investment advice. Figures are as stated by the linked sources.